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Abstract
The development of efficient methods for accessing fluorinated functional groups is desirable.
Herein, we report a two-step method that utilizes catalytic Cu for the decarboxylative
trifluoromethylation of propargyl bromodifluoroacetates. This protocol affords a mixture of
propargyl trifluoromethanes and trifluoromethyl allenes.
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The development of methods that enable the incorporation of the trifluoromethyl group into
organic compounds can impact agricultural chemistry,1 chemical biology,2 material
sciences,3 and medicinal chemistry.2 Among the numerous approaches for
trifluoromethylation,4 copper(0) and copper salts are frequently employed to both generate
and harness reactive CF3 complexes. In recent years, improved methods have enabled the
generation of copper–trifluoromethyl (Cu–CF3) species from common starting materials,
including R3Si–CF3,5 trifluoromethane (CHF3),6 halodifluoroacetates,7 and S-
(trifluoromethyl)diarylsulfonium salts.8 In these reactions, Cu–CF3 complexes typically
display excellent functional group compatibility, and can be used in the presence of hard
electrophiles, such as aldehydes and ketones.6 Further, these species tolerate high
temperatures7b–f and the presence of protic solvents, including water.9
Given these benefits, the reaction of Cu–CF3 species10 with activated electrophiles can
provide trifluoromethanes under mild conditions. A range of allyl, benzyl, propargyl and
aromatic electrophiles react with Cu–CF3 complexes to provide trifluoromethane-containing
products (Scheme 1).5–8 While the use of stoichiometric Cu enables a variety of important
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transformations,4 the principles of green chemistry encourage the development of
trifluoromethylation reactions that only utilize catalytic quantities of copper.11
The conversion of propargyl electrophiles (bromides, chlorides, mesylates, and
trifluoroacetates) into trifluoromethanes represents one such transformation. Several
methods that utilize stoichiometric quantities of Cu–CF3 have been recently reported
(Scheme 2, eq 1–3).12 Depending upon the nature of the substrate and the Cu–CF3 species,
two classes of products were obtained: propargyl trifluoromethanes, and trifluoromethyl
allenes. Most commonly, primary propargyl electrophiles yielded propargyl
trifluoromethanes (Scheme 2, eq 1), whereas secondary substrates provided trifluoromethyl
allenes (Scheme 2, eq 2).12 Propargyl trifluoromethanes were also accessed from secondary
propargyl chlorides; however, the reaction proceeded via the initial formation of
trifluoromethyl allene, followed by a rearrangement that afforded a propargyl
trifluoromethane (Scheme 2, eq 3).12b In addition to these copper-mediated reactions, an
alternate copper-catalyzed trifluoromethylation employed copper(I) thiophenes-2-
carboxylate (CuTC) and trimethyl(trifluoromethyl)silane (TMS–CF3) with potassium
fluoride (KF) as an activator (Scheme 2, eq 4 and 5).13 The regioselectivity of this
transformation was dictated by the substrate, with primary propargyl chlorides providing
propargyl trifluoromethanes (Scheme 2, eq 4), and secondary propargyl chlorides affording
trifluoromethyl allenes (Scheme 2, eq 5).13
In contrast, alternate electrophiles for nucleophilic substitution include propargyl
halodifluoroacetates, which undergo decarboxylative trifluoromethylation upon treatment
with stoichiometric copper(I) iodide (CuI).14 However, only a single example of this
transformation exists, which converts propargyl chlorodifluoroacetate to trifluoromethyl
allene (Scheme 2, eq 6).14 While this strategy utilized decarboxylation as an effective
method to generate reactive fluorinated species, the use of stoichiometric copper(I) iodide
encourages the development of a catalytic process.
In order to establish whether this strategy could be expanded more generally to substituted
propargyl substrates, we subjected 3-phenylpropynyl chlorodifluoroacetate (1–Cl) to the
previously reported conditions utilizing stoichiometric copper(I) iodide.14 Interestingly, this
reaction provided a 1.7:1 mixture of propargyl (2A) and allenyl (2B) products (Scheme 3).
With the goal of developing a catalytic variant of the reaction, subjecting 1–Cl to similar
conditions with 10 mol % of copper(I) iodide provided a low yield of trifluoromethylated
product (Scheme 3).
Given the poor reactivity of chlorodifluoroacetates compared to bromodifluoroacetates,7a, 14
the reaction of 3-phenylpropynl bromodifluoroacetate (1–Br) was explored. Promotion of
the reaction with stoichiometric copper provided 57% of the trifluoromethylated product
with 2.6:1 regioselectivity (Table 1, entry 1). In contrast, catalytic turnover was realized
using just 10 mol % copper(I) iodide, providing the trifluoromethylated product in 65%
yield (Table 1, entry 2). Based on previous work in our laboratory,7a we hypothesized that
the addition of N,N’-dimethylethylenediamine (DMEDA), and the use of an activation
procedure might improve the yield of product. While the use of DMEDA alone was
detrimental to the reaction (Table 1, entry 3), possibly because of the uncatalyzed reaction of
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the amine with the substrate, the employment of DMEDA, sodium bromo(difluoro)acetate
(NaO2CCF2Br) and an activation procedure7a provided 75% of trifluoromethane-containing
product and a 2.7 : 1 ratio of 2A:2B (Table 1, entry 4). Heating copper(I) iodide, DMEDA,
KF, and NaO2CCF2Br in N,N-dimethylformamide at 50 °C for 10 minutes prior to the
addition of substrate may facilitate the formation of an active (DMEDA)Cu–CF3 species
(Scheme 4) and circumvent an induction period during which the substrate could be
destroyed via non-productive pathways.
Attempted optimization of several other parameters did not lead to an improvement in the
yield or selectivity. A broad screen of N- and O-based ligands did not result in increased
yields or selectivity for the formation of 2A. The regioselectivity of the reaction was not
influenced dramatically by temperature, and isomerization was not observed upon prolonged
heating. Incomplete conversion of starting material was observed at 8–10-hour time points;
therefore, an extended reaction time of 14 h was selected for the general reaction conditions.
In addition, various control reactions were conducted to probe the use of copper(I)
thiophenes-2-carboxylate as a catalyst for the present reaction. This salt has been employed
for the regioselective conversion of propargyl chlorides to propargyl trifluoromethanes.13
Treatment of 1-Br with copper(I) thiophenes-2-carboxylate provided a decreased yield
(52%) and similar regiochemical outcome (2.7:1) (Table 1, entry 5). Further, subjection of
1-Br to the exact conditions that facilitated the conversion of propargyl chlorides to
trifluoromethanes [TMSCF3 (1.5 equiv) and KF (1.5 equiv) in THF at 60 °C for 20 h]
formed less than 5% of desired material, which demonstrates that there are inherent
differences in the reactivity of propargyl chlorides and bromodifluoroacetates (Table 1,
entry 6). When this reaction was conducted in the absence of TMSCF3, only 25%
conversion of 1 occurred, which suggests that decarboxylation does not occur under these
conditions (Table 1, entry 7). Based on the results in entries 5–7, we hypothesize that the
selection of appropriate solvent is critical for the present reaction.
The copper(I) iodide/DMEDA-catalyzed trifluoromethylation of propargyl
bromodifluoroacetates (3) tolerates many useful and important functional groups. Electron-
donating aryl ethers provided trifluoromethane-containing products in moderate yield (Table
2, entries 1 and 2). A variety of carbonyl containing functional groups were compatible with
the reaction conditions, including: esters, ketones, carbamates, and trifluoroacetamides
(Table 2, entries 3–6). In addition, the successful reaction of the trifluoroacetamide provided
the desired product, albeit in low yield, which provides additional evidence that Cu–CF3
species tolerate protic functional groups (Table 2, entry 6).9 The present trifluoromethylation
reaction was conducted on an increased scale (7 mmol), and provided a typical yield
according to 19F NMR spectroscopy (Table 2, entry 9). In addition to aromatic substrates, an
aliphatic substrate afforded trifluoromethylated product in moderate yield, and displayed
distinct regioselectivity compared to the aromatic substrates (Table 2, entry 10). Based on
the similarity of propargyl bromodifluoroacetates and cinnamyl bromodifluoroacetates, and
the identical catalyst systems employed for decarboxylative trifluoromethylation, it is
anticipated that other functional groups, including aryl bromides and triflates, thiophenes,
anilines, and phthalimides should be tolerated under the reaction conditions.7a While
attempts were made to separate regioisomeric products, we were unable to achieve sufficient
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separation via standard silica gel chromatography to enable practical isolation of pure
products.
Using the standard reaction conditions, a secondary propargyl substrate was less reactive
than primary substrates, and provided 16% of trifluoromethylated product after 12 hours at
50 °C. However, under more forcing conditions (70 °C, 24 h), both propargyl
trifluoromethane 6A and trifluoromethyl allene 6B were formed (Scheme 5). For the
reactions of propargyl bromodifluoroacetates, both primary and secondary substrates
provided similar regiochemical outcomes, and propargylic trifluoromethanes were observed
as the major product (Scheme 5). In contrast, previous copper-catalyzed trifluoromethylation
reactions of propargyl electrophiles displayed substrate-dependent regioselectivity, with
primary electrophiles providing propargyl trifluoromethanes, and secondary electrophiles
yielding trifluoromethyl allenes (Scheme 2, eq 4 and 5).13
The present copper/DMEDA-based catalyst system demonstrated unique reactivity
compared to other copper-based catalyst systems. Several Cu–CF3 complexes commonly
react with aryl iodides under mild reaction conditions to furnish trifluoromethylarenes.5, 15
In order to determine whether propargylic trifluoromethylation could be selectively achieved
in the presence of aryl iodides, an exogenous aryl iodide was added to a standard
decarboxylative trifluoromethylation reaction.16 The addition of one equivalent of aryl
iodide had no effect on the yield or selectivity of the reaction (Scheme 6, eq 1). GC analysis
of the reaction revealed that 92% of aryl iodide 7 remained unconsumed. In addition, less
than 1% of trifluoromethylarene 8 was observed, which demonstrates the unique reactivity
of this system. In order to confirm that substrates containing aryl iodides were compatible
with the reaction conditions, 4-iodophenylpropynyl bromodifluoroacetate (9) was subjected
to decarboxylative trifluoromethylation. As expected, a good combined yield (80%) of
trifluoromethylated products 10A and 10B was obtained with typical regioselectivity (2.1:1,
Scheme 6, eq 2). Again, only trace amounts of aromatic trifluoromethyl products 4A-8 and
4B-8 (see Table 2, entry 8) were observed.
In conclusion, a two-step, copper-catalyzed protocol enables the conversion of propargyl
bromodifluoroacetic esters into a mixture of propargyl trifluoromethanes and trifluoromethyl
allenes. This decarboxylative strategy utilizes the combination of bromo(difluoro)acetate
and potassium fluoride as an attractive trifluoromethylation reagent that produces carbon
dioxide as a benign, easily separable byproduct. For the copper-catalyzed
trifluoromethylation, the use of DMEDA as a ligand, and an activation procedure, helped
establish the catalyst system. Ongoing work in our laboratory aims to develop more
selective and efficient catalyst systems for the current trifluoromethylation reaction, as well
as other related fluoroalkylation reactions.
Experimental Section
Unless otherwise noted, chemicals were purchased from commercial sources and used
without further purification. Potassium fluoride (spray-dried) was ground to a fine powder
with a mortar and pestle and dried in a vacuum oven (180 °C) for a minimum of 24 h prior
to use. Dry solvents were used directly from a solvent purification system, in which solvent
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was dried by passage through two columns of activated alumina under argon, or purchased
from commercial sources in Sure-Seal® bottles. All reactions were conducted under an
atmosphere of dry N2 using oven-dried glassware. Trifluoromethylation reactions were
performed in resealable 15 mL test tubes sealed with PTFE septa, and all other reactions
were performed in round bottom flasks sealed with rubber septa. Reactions were monitored
by thin-layer chromatography using Analtech UNIPLATETM Silica Gel HLF 250 micron
glass plates precoated with 230–400 mesh silica impregnated with a fluorescent indicator
(250 nm), visualizing with fluorescence quenching or p-anisaldehyde solution. Flash column
chromatography was performed using a CombiFlash® RF–4x purification system. Silica gel
was purchased from Sorbent Technologies (cat. # 30930M-25, 60 Å, 40–63 µm). Yields of
products reported in the experimental section refer to the isolated yield of a single
experiment. 19F NMR yields reported in tables were determined using α,α,α-
trifluorotoluene (TFT) as an internal standard, and represent the average of at least two
independent runs. Uncorrected melting points were measured on a Thomas Hoover
Capillary Melting Point apparatus. Infrared spectra were recorded using a Shimadzu
FTIR-8400S Fourier Transform Infrared Spectrometer. 1H NMR spectra were recorded on a
Bruker 400 Avance spectrometer (400 MHz) or a Bruker 500 Avance spectrometer (500
MHz). 13C NMR spectra were recorded on a Bruker 500 Avance spectrometer (126
MHz). 19F NMR spectra were recorded on a Bruker 400 Avance spectrometer (376 MHz).
Chemical shifts (δ) for protons are reported in parts per million (ppm) downfield from
tetramethylsilane, and are referenced to the proton resonance of residual CHCl3 in the NMR
solvent (δ = 7.27 ppm). Chemical shifts for carbon are reported in parts per million
downfield from tetramethylsilane, and are referenced to the carbon resonances of the solvent
peak (δ = 77.16 ppm). Chemical shifts for fluorine are reported in parts per millions, and are
referenced to α,α,α-trifluorotoluene (δ = −63.72 ppm). Low-resolution mass spectra were
recorded on a Shimatzu GCMS-QP2010 SE mass spectrometer. High-resolution mass
spectra were recorded on a Waters LCT PremierTM mass spectrometer in the ESI mode.
Propargyl Alcohols; Representative Procedure
An oven-dried 25 mL round bottom flask was charged with CuI (76 mg, 0.40 mmol) and
Pd(PPh3)2Cl2 (0.14 g, 0.20 mmol). The flask was sealed and then evacuated and backfilled
with N2 three times. MeCN (0.010 L) and 4-iodoanisole (2.3 g, 0.010 mol) were injected,
and the suspension was cooled to −10 °C. NEt3 (6.3 mL, 45 mmol) was added dropwise, and
the mixture was stirred for 10 min. Propargyl alcohol (0.64 mL, 11 mmol) was injected
dropwise, and then the reaction was allowed to warm to 23 °C. After 4 h, the solvent was
removed in vacuo, and the crude mixture was dissolved in EtOAc (60 mL). The solution was
passed through a pad of silica, which was washed with additional EtOAc (3×30 mL).
Further chromatographic purification (hexanes–EtOAc 1:0→4:1) afforded 3-(4-
methoxyphenyl)prop-2-yn-1-ol as a pale yellow solid (1.56 g, 96%).
Mp 69–70 °C (lit.17 74–75).
1H NMR (400 MHz, CDCl3): δ = 7.42–7.35 (m, 2 H), 6.89−6.81 (m, 2 H), 4.49 (d, J = 6.1
Hz, 2 H), 3.82 (s, 3 H), 1.64 (t, J = 6.1 Hz, 1 H).
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Propargyl Bromodifluoroacetates; Representative Procedure
An oven-dried single-neck round-bottom flask (flask 1) was charged with
bromodifluoroacetic acid (0.74 g, 4.2 mmol), and the system was attached to a bubbler.
DCM (0.010 L) and DMF (0.070 mL, 0.90 mmol) were injected, and then oxalyl chloride
(0.33 mL, 3.9 mmol) was added dropwise. In a separate oven-dried 2-neck round-bottom
flask (flask 2), 3-(4-methoxyphenyl)prop-2-yn-1-ol (0.49 g, 3.0 mmol), NEt3 (0.84 mL, 6.0
mmol) and DCM (0.010 L) were combined, and the system was attached to a bubbler via a
glass adapter. The solution was cooled to 0 °C, and then the solution in flask 1 was
transferred to flask 2 via cannula. The reaction was allowed to warm to 23 °C and stirred for
3 h. The mixture was diluted with DCM (30 mL) and washed with 1 M HCl (25 mL), H2O
(25 mL), and brine (25 mL). The organic solution was dried over anhydrous Na2SO4,
filtered, and the solvent was removed in vacuo. Chromatographic purification (hexanes–
EtOAc 19:1) afforded 3-(4-methoxyphenyl)prop-2-yn-1-yl 2-bromo-2,2-difluoroacetate as a
colorless oil (540 mg, 56%).
IR (film): 3010, 2839, 1780, 1606, 1510, 1290, 1249, 1172, 1120, 1031, 946, 833, 709, 603
cm−1.
1H NMR (400 MHz, CDCl3): δ = 7.47−7.38 (m, 2 H), 6.91−6.79 (m, 2 H), 5.16 (s, 2 H),
3.83 (s, 3 H).
13C NMR (126 MHz, CDCl3): δ = 160.4, 159.2 (t, J = 31.9 Hz), 133.7, 114.1, 113.5, 108.6
(t, J = 314.4 Hz), 88.9, 79.1, 56.8, 55.4.
19F NMR (376 MHz, CDCl3): δ = −62.30 (s, 2 F).
HRMS (EI): m/z [M]+ calcd for C12H9BrF2O3: 317.9703; found: 317.9700.
Trifluoromethane-Containing Compounds; General Procedure
KF (23 mg, 0.40 mmol) was added to a resealable 15 mL test tube and dried in a vacuum
oven for a minimum of 24 h. The test tube was removed from the oven, sealed with a PTFE
septum, and cooled under N2. CuI (3.8 mg, 0.020 mmol) and NaO2CCF2Br (9.8 mg, 0.050
mmol) were added, and the test tube was evacuated and backfilled with N2 three times.
DMEDA (2.2 µL, 0.020 mmol) and DMF (0.20 mL) were injected into the test tube, which
was placed into an oil bath at 50 °C. The mixture was heated for 10 min, during which
bubbling was observed and the solution changed from teal/blue to yellow. Next, propargyl
bromodifluoroacetate (0.20 mmol) was injected into the test tube, and heating was
maintained for 14 h. The mixture was diluted with EtOAc (3 mL), and TFT (24.6 µL, 0.200
mmol) was added as an internal standard. An aliquot was removed, and a 19F NMR
spectrum was obtained. The aliquot was recombined, and the reaction mixture was diluted
further with EtOAc (15 mL). The organic solution was washed with aq NH4Cl solution (10
mL) and brine (10 mL), dried over anhydrous Na2SO4, filtered, and the solvent was
removed in vacuo. Chromatographic purification afforded a mixture of propargyl
trifluoromethane (A) and trifluoromethyl allene (B). The ratio or regioisomers was
determined by 1H NMR spectroscopy (propargylic CH2/terminal CH2 of allene). Note: the
Ambler et al. Page 6






















following numbering system is used for compounds 4: 4A/B-x, where×is an integer referring
to the specific entry in Table 2.
Compounds 4A/B-113,18
The general procedure was followed using 3-(4-methoxyphenyl)prop-2-yn-1-yl 2-
bromo-2,2-difluoroacetate (64 mg, 0.20 mmol), CuI (3.8 mg, 0.020 mmol), DMEDA (2.2
µL, 0.020 mmol), NaO2CCF2Br (9.8 mg, 0.050 mmol), KF (23 mg, 0.40 mmol), with DMF
(0.20 mL) as solvent. Workup and chromatographic purification (hexanes–EtOAc
1:0→49:1) afforded a mixture of regioisomers as a yellow oil (31 mg, 72%). Analysis of
the 1H NMR spectrum revealed a 4.0:1 ratio of A/B.
1H NMR (400 MHz, CDCl3): δ = 7.43–7.34 (m, 4 H, A/B), 6.94–6.89 (m, 2 H, B), 6.88–
6.82 (m, 2 H, A), 5.51 (q, J = 3.4 Hz, 2 H, B), 3.83 (s, 3 H, B), 3.82 (s, 3 H, A), 3.26 (q, J =
9.6 Hz, 2 H, A).
19F NMR (376 MHz, EtOAc): δ = −61.76 (t, J = 3.6 Hz, 3 F, B), −67.76 (t, J = 10.0 Hz, 3 F,
A).
Compounds 4A/B-2
The general procedure was followed using 3-(2-methoxy-5-nitrophenyl)prop-2-yn-1-yl 2-
bromo-2,2-difluoroacetate (73 mg, 0.20 mmol), CuI (3.8 mg, 0.020 mmol), DMEDA (2.2
µL, 0.020 mmol), NaO2CCF2Br (9.8 mg, 0.050 mmol), KF (23 mg, 0.40 mmol), with DMF
(0.20 mL) as solvent. Workup and chromatographic purification (hexanes–EtOAc 1:0→3:1)
afforded a mixture of regioisomers as a colorless solid (36 mg, 70%). Analysis of the 1H
NMR spectrum revealed a 2.1:1 ratio of A/B.
Mp 76–81 °C.
IR (film): 3119, 3094, 2947, 2920, 2847, 1983, 1610, 1580, 1514, 1493, 1492, 1439, 1418,
1344, 1275, 1246, 1190, 1148, 1103, 1018, 968, 906, 891, 868, 833, 797, 750, 735, 694,
665, 638 cm−1.
1H NMR (400 MHz, CDCl3): δ = 8.31 (d, J = 2.8 Hz, 1 H, A), 8.28 (dd, J = 9.1, 2.8 Hz, 1 H,
B), 8.24–8.20 (m, 2 H, A/B), 7.01 (d, J = 9.1 Hz, 1 H, B), 6.96 (d, J = 9.2 Hz, 1 H, A), 5.42
(q, J = 3.4 Hz, 2 H, B), 4.00 (s, 3 H, A), 3.96 (s, 3 H, B), 3.35 (q, J = 9.5 Hz, 2 H, A).
13C NMR (126 MHz, CDCl3): δ = 209.41 (q, J = 3.7 Hz, B), 164.97 (A), 162.43 (B), 141.23
(B), 141.09 (A), 129.59 (A), 126.67 (B), 126.51 (B), 126.21 (A), 124.10 (q, J = 277.0 Hz,
A), 122.87 (q, J = 273.9 Hz, B), 119.90 (B), 112.56 (A), 110.98 (B), 110.48 (A), 95.74 (q, J
= 37.2 Hz, B), 83.93 (q, J = 5.0 Hz, A), 82.19 (B), 78.61 (A), 56.79 (A), 56.58 (B), 27.15 (q,
J = 34.9 Hz, A).
19F NMR (376 MHz, CDCl3): δ = −62.45 (t, J = 3.5 Hz, 3 F, B), −67.35 (t, J = 9.9 Hz, 3 F,
A).
MS (CI): m/z [M]+ calcd for C11H8F3NO3: 259.0; found: 259.0.
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The general procedure was followed using ethyl 3-(3-(2-bromo-2,2-difluoroacetoxy)prop-1-
yn-1-yl)benzoate (72 mg, 0.20 mmol), CuI (3.8 mg, 0.020 mmol), DMEDA (2.2 µL, 0.020
mmol), NaO2CCF2Br (9.8 mg, 0.050 mmol), KF (23 mg, 0.40 mmol), with DMF (0.20 mL)
as solvent. Workup and chromatographic purification (hexanes–EtOAc 1:0→49:1) afforded
a mixture of regioisomers as a pale green oil (0.040 g, 78%). Analysis of the 1H NMR
spectrum revealed a 2.3:1 ratio of A/B.
IR (film): 3067, 2984, 2932, 2854, 1971, 1720, 1472, 1367, 1298, 1256, 1231, 1173, 1148,
1111, 1084, 1026, 908, 872, 754 cm−1.
1H NMR (400 MHz, CDCl3): δ = 8.16–8.09 (m, 2 H, A/B), 8.05–7.97 (m, 2 H, A/B), 7.66–
7.60 (m, 2 H, A/B), 7.47 (t, J = 7.8 Hz, 1 H, B), 7.41 (t, J = 7.8 Hz, 1 H, A), 5.61 (q, J = 3.4
Hz, 2 H, B), 4.46–4.33 (m, 4 H, A/B), 3.30 (q, J = 9.5 Hz, 2H, A), 1.41 (t, J = 7.1 Hz, 6 H,
A/B).
13C NMR (126 MHz, CDCl3): δ = 208.71 (q, J = 4.0 Hz, B), 166.23 (B), 165.92 (A), 136.02
(A), 133.06 (A), 131.27 (B), 131.26 (q, J = 1.3 Hz, B), 130.94 (A), 129.85 (A), 129.79 (B),
129.39 (B), 128.94 (B), 128.59 (A), 128.44 (B), 124.24 (q, J = 277.4 Hz, A), 123.28 (q, J =
273.9 Hz, B), 122.65 (A), 101.42 (q, J = 35.7 Hz, B), 84.23 (B), 83.56 (A), 78.59 (q, J = 5.1
Hz, A), 61.42 (A), 61.38 (B), 26.93 (q, J = 34.9 Hz, A), 14.46 (A/B).
19F NMR (376 MHz, CDCl3): δ = −61.59 (t, J = 3.6 Hz, 3 F, B), −67.51 (t, J = 10.0 Hz, 3 F,
A).
MS (CI): m/z [M]+ calcd for C13H11F3O2: 256.1; found: 256.1.
Compounds 4A/B-4
The general procedure was followed using 3-(4-acetylphenyl)prop-2-yn-1-yl 2-bromo-2,2-
difluoroacetate (66 mg, 0.20 mmol), CuI (3.8 mg, 0.020 mmol), DMEDA (2.2 µL, 0.020
mmol), NaO2CCF2Br (9.8 mg, 0.050 mmol), KF (23 mg, 0.40 mmol), with DMF (0.20 mL)
as solvent. Workup and chromatographic purification (hexanes–EtOAc 1:0→49:1) afforded
a mixture of regioisomers as a yellow oil (0.030 g, 66%). Analysis of the 1H NMR spectrum
revealed a 2.6:1 ratio of A/B.
IR (film): 3067, 2964, 2932, 2854, 1969, 1933, 1686, 1603, 1558, 1418, 1404, 1362, 1306,
1263, 1178, 1150, 1109, 1016, 957, 935, 906, 833, 717, 679, 628, 592 cm−1.
1H NMR (400 MHz, CDCl3): δ = 7.99–7.94 (m, 2 H, B), 7.94–7.89 (m, 2 H, A), 7.57–7.52
(m, 4 H, A/B), 5.64 (q, J = 3.3 Hz, 2 H, B), 3.32 (q, J = 9.5 Hz, 2 H, A), 2.62 (s, 3 H, B),
2.61 (s, 3 H, A).
13C NMR (126 MHz, CDCl3): δ = 209.23 (q, J = 3.9 Hz, B), 197.50 (B), 197.42 (A), 136.80
(A), 136.60 (B), 134.07 (B), 132.15 (A), 129.99 (A), 128.85 (B), 128.35 (A), 127.17 (q, J =
1.3 Hz, B), 127.08 (A), 124.13 (q, J = 277.4 Hz, A) 123.17 (q, J = 273.9 Hz, B), 101.72 (B),
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84.45 (B), 83.74 (A), 80.99 (q, J = 5.1 Hz, A), 27.03 (q, J = 35.0 Hz, A), 26.81 (A), 26.78
(B).
19F NMR (376 MHz, EtOAc): δ = −63.30 to −63.53 (m, 3 F, B), −67.66 (t, J = 10.0 Hz, 3 F,
A).
MS (CI): m/z [M]+ calcd for C12H9F3O: 226.1; found: 226.1.
Compounds 4A/B-5
The general procedure was followed using tert-butyl 3-(3-(2-bromo-2,2-
difluoroacetoxy)prop-1-yn-1-yl)-1H-indole-1-carboxylate (86 mg, 0.20 mmol), CuI (3.8 mg,
0.020 mmol), DMEDA (2.2 µL, 0.020 mmol), NaO2CCF2Br (9.8 mg, 0.050 mmol), KF (23
mg, 0.40 mmol), with DMF (0.20 mL) as solvent. Workup and chromatographic purification
(hexanes–EtOAc 1:0→9:1) afforded a mixture of regioisomers as a viscous orange oil (38
mg, 59%). Analysis of the 1H NMR spectrum revealed a 3.0:1 ratio of A/B.
IR (film): 3159, 3055, 2980, 2932, 2851, 1740, 1558, 1475, 1454, 1420, 1375, 1357, 1308,
1279, 1234, 1256, 1234, 1111, 1049, 1032, 854, 831, 746, 729 cm−1.
1H NMR (400 MHz, CDCl3): δ = 8.19 (d, J = 8.5 Hz, 1 H, B), 8.15 (d, J = 8.2 Hz, 1 H, A),
7.87 (dt, J = 8.0, 1.0 Hz, 1 H, B), 7.79 (s, 1 H, A), 7.73 (s, 1 H, B), 7.68–7.60 (m, 1 H, A),
7.37 (td, J = 7.8, 1.4 Hz, 2 H, A/B), 7.31 (td, J = 7.5, 1.1 Hz, 1 H, A), 7.29–7.24 (m, 1 H, B),
5.69 (qd, J = 3.0, 0.9 Hz, 2 H, B), 3.37 (q, J = 9.6 Hz, 2 H, A), 1.70 (s, 9 H, B), 1.68 (s, 9 H,
A).
13C NMR (126 MHz, CDCl3): δ = 208.94 (q, J = 3.7 Hz, B), 149.49 (B), 149.12 (A), 135.48
(B), 134.66 (A), 130.53 (A), 129.57 (A), 128.40 (B), 125.40 (A), 125.17 (B), 124.35 (q, J =
277.1 Hz, A), 124.21 (q, J = 1.3 Hz, B), 123.41 (A), 123.33 (q, J = 273.7 Hz, B), 123.07
(B), 120.07 (A), 119.93 (B), 115.46 (B), 115.40 (A), 107.96 (B), 102.44 (A), 95.70 (q, J =
36.1 Hz, B), 84.59 (A), 84.58 (A) 84.52 (B), 81.08 (q, J = 5.1 Hz, A), 76.64 (B) 28.30 (B),
28.28 (A), 27.20 (q, J = 34.8 Hz, A).
19F NMR (376 MHz, CDCl3): δ = −63.41 (t, J = 3.5 Hz, 3 F, B), −67.66 (t, J = 9.9 Hz, 3 F,
A).
HRMS (ESI): m/z [2 M + Na]+ calcd for C34H32F6N2O4Na: 669.2164; found: 669.2179.
Compounds 4A/B-6
The general procedure was followed using 3-(4-(2,2,2-trifluoroacetamido)phenyl)prop-2-
yn-1-yl 2-bromo-2,2-difluoroacetate (80 mg, 0.20 mmol), CuI (3.8 mg, 0.020 mmol),
DMEDA (2.2 µL, 0.020 mmol), NaO2CCF2Br (9.8 mg, 0.050 mmol), KF (23 mg, 0.40
mmol), with DMF (0.20 mL) as solvent. Workup and chromatographic purification
(hexanes–DCM 1:0→1:1) afforded a mixture of regioisomers as a colorless solid (24 mg,
40%). Analysis of the 1H NMR spectrum revealed a 6.3:1 ratio of A/B.
IR (film): 3300, 3202, 3136, 2964, 1705, 1607, 1547 1512, 1410, 1366, 1281, 1246, 1202,
1155, 1107, 959, 906, 839, 727, 704, 654 cm−1.
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1H NMR (500 MHz, CDCl3): δ = 7.89 (s, 1 H, A), 7.83 (s, 1 H, B), 7.62–7.58 (m, 2 H, B),
7.58–7.54 (m, 2 H, A), 7.52–7.45 (m, 4 H, A/B), 5.60 (q, J = 3.4 Hz, 2 H, B), 3.29 (q, J =
9.5 Hz, 2 H, A).
13C NMR (126 MHz, CDCl3): δ = 208.65 (q, J = 4.4 Hz, B), 154.89 (q, J = 37.5 Hz, B),
154.80 (q, J = 37.5 Hz, A), 135.38 (A), 135.00 (B), 133.10 (A), 128.16 (q, J = 1.5 Hz, B),
124.25 (q, J = 276.9 Hz, A), 123.29 (q, J = 275.6 Hz, B), 120.71 (A), 120.32 (B), 120.25
(A), 120.18 (B), 115.70 (q, J = 288.8, B), 115.69 (q, J = 288.8 Hz, A), 101.24 (q, J = 35.4
Hz, B), 84.25 (B), 83.51 (A), 78.48 (q, J = 5.0 Hz, A), 26.94 (q, J = 34.8 Hz, A).
19F NMR (376 MHz, CDCl3): δ = −61.55 (t, J = 3.0 Hz, 3 F, B), −67.35 (t, J = 9.5 Hz, 3 F,
A), −76.69 (6 F, A/B).
MS (CI): m/z [M]+ calcd for C12H7F6NO: 295.0; found: 295.0.
Compounds 4A/B-7
The general procedure was followed using 3-(3,4-dichlorophenyl)prop-2-yn-1-yl 2-
bromo-2,2-difluoroacetate (72 mg, 0.20 mmol), CuI (3.8 mg, 0.020 mmol), DMEDA (2.2
µL, 0.020 mmol), NaO2CCF2Br (9.8 mg, 0.050 mmol), KF (23 mg, 0.40 mmol), with DMF
(0.20 mL) as solvent. Workup and chromatographic purification (hexanes) afforded a
mixture of regioisomers as a pale yellow oil (0.040 g, 79%). Analysis of the 1H NMR
spectrum revealed a 2.2:1 ratio of A/B.
IR (film): 3074, 2928, 1973, 1533, 1475, 1466, 1364, 1352, 1281, 1254, 1178, 1151, 1130,
1111, 1034, 906, 881, 822 cm−1.
1H NMR (400 MHz, CDCl3): δ = 7.55 (d, J = 2.0 Hz, 1 H, A), 7.52 (d, J = 2.2 Hz, 1 H, B),
7.45 (d, J = 8.5 Hz, 1 H, B), 7.40 (d, J = 8.3 Hz, 1 H, A), 7.30–7.26 (m, 4 H, A/B), 5.63 (q, J
= 3.3 Hz, 2 H, B), 3.28 (q, J = 9.5 Hz, 2 H, A).
13C NMR (126 MHz, CDCl3): δ = 208.60 (q, J = 3.9 Hz, B), 133.64 (A), 133.41 (A), 133.16
(B), 132.75 (A), 132.58 (B), 131.10 (A), 130.80 (B), 130.54 (A), 129.38 (B), 129.03 (q, J =
1.7 Hz, B), 126.30 (q, J = 1.7 Hz, B), 124.12 (q, J = 276.9 Hz, A), 123.02 (q, J = 273.1 Hz,
B), 122.18 (A), 100.59 (q, J = 35.2 Hz, B), 84.69 (B), 82.28 (A), 79.80 (q, J = 5.1 Hz, A),
26.92 (q, J = 34.9 Hz, A).
19F NMR (376 MHz, EtOAc): δ = −61.59 (t, J = 3.6 Hz, 3 F, B), −67.51 (t, J = 10.0 Hz, 3 F,
A).
HRMS (EI): m/z [M]+ calcd for C10H5Cl2F3: 251.9720; found: 251.9721.
Compounds 4A/B-8
The general procedure was followed using 3-(4-(trifluoromethyl)phenyl)prop-2-yn-1-yl 2-
bromo-2,2-difluoroacetate (71 mg, 0.20 mmol), CuI (3.8 mg, 0.020 mmol), DMEDA (2.2
µL, 0.020 mmol), NaO2CCF2Br (9.8 mg, 0.050 mmol), KF (23 mg, 0.40 mmol), with DMF
(0.20 mL) as solvent. Workup and chromatographic purification (hexanes–EtOAc
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1:0→49:1) afforded a mixture of regioisomers as a colorless oil (35 mg, 70%). Analysis of
the 1H NMR spectrum revealed a 1.7:1 ratio of A/B.
IR (film): 3063, 2934, 1971, 1927, 1618, 1406, 1366, 1329, 1281, 1267, 1151, 1130, 1105,
1068, 1018, 937, 906, 870, 843, 735, 723 cm−1.
1H NMR (400 MHz, CDCl3): δ = 7.67–7.53 (m, 8 H, A/B), 5.64 (q, J = 3.4 Hz, 2 H, B),
3.31 (q, J = 9.5 Hz, 2 H, A).
13C NMR (126 MHz, CDCl3): δ = 209.04 (q, J = 4.1 Hz, B), 133.10 (q, J = 1.6 Hz, B),
132.27 (A), 130.64 (q, J = 32.7 Hz, A), 130.36 (q, J = 32.7 Hz, B), 127.41 (q, J = 1.6 Hz,
B), 126.06 (q, J = 1.7 Hz, A), 125.82 (q, J = 3.8 Hz, B), 125.42 (q, J = 3.9 Hz, A), 124.15
(q, J = 278.6 Hz, A), 124.02 (q, J = 272.2 Hz, B), 123.93 (q, J = 271.8 Hz, A), 123.13 (q, J
= 274.8 Hz, B), 101.33 (q, J = 35.0 Hz, B), 84.47 (B), 83.21 (A), 80.23 (q, J = 5.1 Hz, A),
26.96 (q, J = 34.9 Hz, A).
19F NMR (376 MHz, EtOAc): δ = −61.50 (t, J = 3.5 Hz, 3 F, B), −63.79 (3 F, B), −63.93 (3
F, A), −67.42 (t, J = 9.9 Hz, 3 F, A).
MS (CI): m/z [M]+ calcd for C11H6F6: 252.0; found: 252.0.
Compounds 4A/B-913, 18
The general procedure was followed using 3-(naphthalen-2-yl)prop-2-yn-1-yl 2-bromo-2,2-
difluoroacetate (2.4 g, 7.0 mmol), CuI (130 mg, 0.70 mmol), DMEDA (75 µL, 0.70 mmol),
NaO2CCF2Br (0.35 g, 1.8 mmol), KF (0.81 g, 14 mmol), with DMF (7.0 mL) as solvent.
Workup and chromatographic purification (hexanes–EtOAc 1:0→49:1) afforded a mixture
of regioisomers as a pale yellow solid (0.93 g, 57%). Analysis of the 1H NMR spectrum
revealed a 3.8:1 ratio of A/B.
Mp 42–45 °C.
1H NMR (400 MHz, CDCl3): δ = 8.00 (s, 1 H, A), 7.93 (s, 1 H, B), 7.88–7.77 (m, 6 H, A/B),
7.57–7.47 (m, 6 H, A/B), 5.63 (q, J = 3.3 Hz, 2 H, B), 3.34 (q, J = 9.6 Hz, 2 H, B).
19F NMR (376 MHz, CDCl3): δ = −61.30 (t, J = 3.6 Hz, 3 F, B), −67.56 (t, J = 10.1 Hz, 3 F,
A).
Compounds 4A/B-10
The general procedure was followed using 5-phenylpent-2-yn-1-yl 2-bromo-2,2-
difluoroacetate (63 mg, 0.20 mmol), CuI (3.8 mg, 0.020 mmol), DMEDA (2.2 µL, 0.020
mmol), NaO2CCF2Br (9.8 mg, 0.050 mmol), KF (23 mg, 0.40 mmol), with DMF (0.20 mL)
as solvent. Workup and chromatographic purification (hexanes) afforded a mixture of
regioisomers as a tan oil (0.030 g, 70%). Analysis of the 1H NMR spectrum revealed a 1:2.1
ratio of A/B.
IR (film): 3088, 3065, 3030, 2932, 2862, 1985, 1954, 1605, 1497, 1454, 1366, 1333, 1281,
1261, 1200, 1157, 1115, 1055, 980, 908, 864, 744, 700 cm−1.
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1H NMR (400 MHz, CDCl3): δ = 7.37–7.28 (m, 4 H, A/B), 7.26–7.19 (m, 6 H, A/B), 5.18
(sext, J = 3.6 Hz, 2 H, B), 3.01 (qt, J = 9.7, 2.4 Hz, 2 H, A), 2.90–2.73 (m, 4 H, A/B), 2.54–
2.41 (m, 4 H, A/B).
13C NMR (126 MHz, CDCl3): δ = 206.73 (q, J = 4.1 Hz, B), 140.80 (B), 140.54 (A), 128.59
(A/B), 128.56 (B), 128.52 (A), 126.48 (A), 126.35 (B), 124.53 (q, J = 277.8 Hz, A), 123.94
(q, J = 274.5 Hz, B), 98.11 (q, J = 34.0 Hz, B), 84.28 (A), 82.54 (B), 69.21 (q, J = 5.1 Hz,
A), 34.94 (A), 33.64 (B), 27.70 (B), 26.28 (q, J = 34.6 Hz, A), 20.99 (A).
19F NMR (376 MHz, CDCl3): δ = −61.60 (t, J = 3.7 Hz, 3 F, B), −67.54 (t, J = 10.0 Hz, 3 F,
A).
MS (CI): m/z [M]+ calcd for C12H11F3: 212.1; found: 212.1.
Compounds 6A/B
The general procedure was followed using 4-(3-nitrophenyl)but-3-yn-2-yl 2-bromo-2,2-
difluoroacetate (70 mg, 0.20 mmol), CuI (3.8 mg, 0.020 mmol), DMEDA (2.2 µL, 0.020
mmol), NaO2CCF2Br (9.8 mg, 0.050 mmol), KF (23 mg, 0.40 mmol), with DMF (0.20 mL)
as solvent. Workup and chromatographic purification (hexanes–EtOAc 1:0→9:1) afforded a
mixture of regioisomers as a yellow oil (0.020 g, 41%). Analysis of the 1H NMR spectrum
revealed a 1.6:1 ratio of A/B (single run).
IR (film): 3090, 2961, 2926, 2856, 1963, 1535, 1481, 1441, 1352, 1327, 1248, 1178, 1155,
1119, 980, 964, 926, 901, 806, 739, 710, 687 cm−1.
1H NMR (400 MHz, CDCl3): δ = 8.41–8.37 (m, 1 H, A), 8.32–8.24 (m, 2 H, A/B), 8.20–
8.14 (m, 1 H, B), 7.85–7.80 (m, 1 H, A), 7.79–7.73 (m, 1 H, B), 7.63–7.53 (m, 2 H, A/B),
6.08 (qt, J = 7.5, 3.1 Hz, 1 H, B), 4.43 (qq, J = 7.8, 2.5 Hz, 1 H, A), 1.97–1.93 (m, 6 H,
A/B).
13C NMR (126 MHz, CDCl3): δ = 205.60 (q, J = 3.9 Hz, B), 148.66 (B), 148.47 (A), 135.54
(A), 134.62 (B), 132.72 (q, J = 1.8 Hz, B), 129.79 (B), 129.74 (A), 124.62 (A) 124.61 (B),
124.09 (q, J = 280.4 Hz, A), 124.00 (A), 123.07 (q, J = 274.8 Hz, B), 122.85 (A), 122.19 (q,
J = 1.8 Hz, B), 100.12 (q, J = 35.3 Hz, B), 96.56 (B), 83.59 (A), 70.34 (q, J = 3.4 Hz, A),
43.30 (q, J = 31.8 Hz, A), 13.37 (B), 3.79 (A).
19F NMR (376 MHz, CDCl3): δ = −61.70 (s, 3 F, B), −71.74 (d, J = 7.5 Hz, 3 F, A).
MS (CI): m/z [M]+ calcd for C11H8F3NO2: 243.1; found: 243.1.
Compounds 10A/B
The general procedure was followed using 3-(4-iodophenyl)prop-2-yn-1-yl 2-bromo-2,2-
difluoroacetate (83 mg, 0.20 mmol), CuI (3.8 mg, 0.020 mmol), DMEDA (2.2 µL, 0.020
mmol), NaO2CCF2Br (9.8 mg, 0.050 mmol), KF (23 mg, 0.40 mmol), with DMF (0.20 mL)
as solvent. Workup and chromatographic purification (hexanes) afforded a mixture of
regioisomers as an amorphous tan solid (0.050 g, 80%). Analysis of the 1H NMR spectrum
revealed a 2.0:1 ratio of A/B.
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IR (film): 3065, 2978, 1961, 1541, 1485, 1391, 1366, 1319, 1279, 1263, 1254, 1173, 1148,
1111, 1061, 1007, 935, 906, 868, 820, 743, 665 cm−1.
1H NMR (400 MHz, CDCl3): δ = 7.73–7.69 (m, 2 H, B), 7.69–7.64 (m, 2 H, A), 7.21–7.15
(m, 4 H, A/B), 5.56 (q, J = 3.4 Hz, 2 H, B), 3.27 (q, J = 9.5 Hz, 2 H, A).
13C NMR (126 MHz, CDCl3): δ = 208.50 (q, J = 4.0 Hz, B), 138.00 (B), 137.66 (A), 133.47
(A/B), 128.87 (q, J = 1.5 Hz, B), 124.18 (q, J = 276.9 Hz, A), 123.19 (q, J = 273.6 Hz, B),
121.78 (A), 94.88 (A), 94.13 (B), 84.23 (A), 83.60 (B), 79.14 (q, J = 5.1 Hz, A), 26.99 (q, J
= 34.9 Hz, A). Note: Terminal substituted carbon of allene B could not be distinguished
from the baseline [expected to be a quartet (J ≈ 35 Hz) between δ 102–100].
19F NMR (376 MHz, EtOAc): δ = −61.60 (t, J = 3.7 Hz, 3 F, B), −67.54 (t, J = 10.0 Hz, 3 F,
A).
MS (CI): m/z [M]+ calcd for C10H6F3I: 310.0; found: 310.0.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Generation of Cu–CF3 from various reagents enables the synthesis of trifluoromethane-
containing products
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Methods for the conversion of propargyl electrophiles into trifluoromethanes
Ambler et al. Page 16























Decarboxylative trifluoromethylation provides a mixture of products
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Activation provides access into the proposed catalytic cycle
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Copper-catalyzed decarboxylative trifluoromethylation of secondary propargyl
bromodifluoroacetates displays atypical reactivity. The ratio of products represents an
average of multiple runs
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Propargylic trifluoromethylation is accomplished selectively in the presence of aryl iodides
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Table 1





Activationb % Yieldc (A : B)d
1e I (100) 0 – 57 (2.6 : 1)
2 I (10) 0 – 65 (3.3 : 1)
3 I (10) 10 – 51 (3.6 : 1)
4 I (10) 10 √ 75 (2.7 : 1)
5 TC (10) 10 √ 52 (2.7 : 1)
6f,g TC (5) 0 – <5 (N.D.)
7f,h TC (5) 0 – 0 (–)
a
Reactions were performed with 1-Br (0.20 mmol), and KF (0.40 mmol) in DMF (0.20 mL).
b
Activation involved heating CuI, DMEDA, NaO2CCF2Br, and KF in DMF for 10 min prior to injection of 1-Br.
c
Combined yield of 2A and 2B as determined by 19F NMR analysis, using α,α,α-trifluorotoluene as an internal standard.
d




KF (0.30 mmol), THF (1.2 mL), 20 h.
g
TMSCF3 (0.30 mmol) was added to the reaction.
h
75% of 1-Br remained, as determined by 19F NMR spectroscopic analysis.
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Table 2
Copper(I) Iodide/DMEDA-Catalyzed Reaction Tolerating Important Functional Groupsa
Entry Product Yield (%)b A:Bc
1 72 (77) 4.0:1 (3.5:1)
2 70 (78) 2.1:1 (2.3:1)
3 78 (83) 2.3:1 (2.6:1)
4 66 (70) 2.6:1 (2.9:1)
5 59 (62) 3.0:1 (2.9:1)
6 40 (44) 6.3:1 (3.4:1)
7 79 (84) 2.2:1 (2.5:1)
8 70 (73) 1.7:1 (1.8:1)
9d 57 (77) 3.8:1 (2.2:1)
10 70 (69) 1:2.1 (1:1.6)
a
Reactions were performed with 3 (0.20 mmol), CuI (0.020 mmol), DMEDA (0.020 mmol), NaO2CCF2Br (0.050 mmol), and KF (0.40 mmol) in
DMF (0.20 mL) at 50 °C for 14 h following 10 min activation period.
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b
Isolated yield of a purified mixture of regioisomers 4A and 4B; the figure in parentheses represents the combined yield of 4A and 4B as
determined by 19F NMR spectroscopic analysis, using α,α,α-trifluorotoluene as an internal standard.
c
Ratio of regioisomers in the isolated material as determined by 1H NMR spectroscopic analysis; the ratio in parentheses represents the ratio of
isomers in the crude reaction mixture as determined by 19F NMR spectroscopic analysis.
d
Reaction conducted on a 7 mmol scale.
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